What does ferulic acid do for the skin?

Ferulic acid stabilizes vitamins C and E in topical serums against UV-induced degradation, approximately doubling their photoprotective efficacy when combined at around 0.5% ferulic acid with 15% ascorbic acid and 1% tocopherol. It also independently absorbs UV radiation and scavenges free radicals generated by sun exposure, reducing oxidative damage to keratinocytes; at 12–14% concentrations it is used in chemical peel formulations for brightening and antioxidant purposes.

What are the best food sources of ferulic acid?

Rice bran and wheat bran are among the richest sources, providing approximately 8 μg/mL and 7.3 μg/mL of ferulic acid respectively as measured by HPLC, while bamboo shoots contribute approximately 1.7 μg/mL. It also occurs in seeds, leaves, and roots of fruits, vegetables, and cereals broadly across the plant kingdom, though most is bound to cell wall polysaccharides and requires enzymatic or alkaline hydrolysis for full release and absorption.

Is ferulic acid safe to take as a supplement?

In vitro studies confirm no cytotoxicity at concentrations up to 100 μg/mL in macrophage cell cultures, and animal pharmacokinetic studies at doses up to 521 μmol/kg report no adverse effects. However, no long-term human safety trials, established maximum tolerated doses, or pregnancy safety data have been published, so supplemental use beyond dietary intake should be approached cautiously and under medical guidance, particularly for individuals on immunosuppressants or antihypertensives.

How is ferulic acid absorbed in the body?

Ferulic acid is rapidly absorbed in the human gastrointestinal tract, reaching peak plasma concentrations at approximately 24 minutes after ingestion, with an estimated plasma half-life of around 10 minutes for free acid; in rats, peak occurs within 2 minutes and elimination half-lives range from 60 to 106 minutes. The compound is extensively metabolized by phase II conjugation, with approximately 84% of urinary metabolites appearing as sulfoglucuronides, and fecal recovery is very low (0.5–0.8% in rats), indicating efficient systemic absorption.

Does ferulic acid have antiviral properties?

Preclinical cell-based studies show ferulic acid inhibits adenovirus serotypes 8 and 11 with EC50 values of 52.5 and 23.3 μg/mL, respectively, and suppresses RSV-induced MIP-2 chemokine production by 42.8–74.4% at concentrations of 50–500 μg/mL in murine macrophages. It also inhibits the proteases of enterovirus 71 and coxsackievirus A16 with IC50 values of 40.82 and 47.87 μg/mL; however, all antiviral data to date are from in vitro or animal models and have not been confirmed in human clinical trials.

What is the difference between ferulic acid and other phenolic antioxidants like caffeic acid?

Ferulic acid and caffeic acid are both phenolic compounds, but ferulic acid has a methoxy group (-OCH₃) in addition to its hydroxyl group, which enhances its lipophilicity and allows it to penetrate lipid bilayers more effectively. This structural difference makes ferulic acid superior at suppressing intracellular reactive oxygen species (ROS) and inhibiting lipid peroxidation in membrane systems. Ferulic acid also demonstrates more potent anti-inflammatory effects by suppressing nitric oxide production more effectively than structurally similar phenolics.

How much ferulic acid should I take daily as a supplement?

Most clinical studies demonstrating antioxidant and anti-inflammatory benefits used ferulic acid concentrations of 50–100 μg/mL in cell culture models, though optimal human oral dosing has not been standardized in published guidelines. Typical supplement formulations contain 50–250 mg of ferulic acid per serving, often in combination with vitamin C and vitamin E for synergistic antioxidant effects. Consult a healthcare provider for personalized dosing recommendations, as individual needs vary based on health status and dietary intake.

Is ferulic acid suitable for people with sensitive skin or inflammatory skin conditions?

Ferulic acid's potent anti-inflammatory action—suppressing nitric oxide production by approximately 74% at therapeutic concentrations—makes it potentially beneficial for individuals with inflammatory skin conditions such as rosacea, dermatitis, or acne. Its strong antioxidant capacity (suppressing intracellular ROS by ~76% at 100 μg/mL) also helps protect the skin barrier from oxidative stress-induced damage. However, topical application concentration and formulation pH should be considered, as highly acidic preparations may irritate sensitive skin; start with lower concentrations to assess individual tolerance.

Ferulic Acid

Ferulic acid is a phenolic hydroxycinnamic acid that exerts antioxidant effects by scavenging free radicals (approximately 20% DPPH inhibition at 20 μM), suppressing ROS by 76% and nitric oxide production by 74% at 100 μg/mL in LPS-stimulated macrophages, and inhibiting lipid peroxidation through electron donation from its conjugated side chain. In preclinical antiviral studies, it demonstrated EC50 values of 52.5 and 23.3 μg/mL against adenovirus serotypes 8 and 11, and reduced RSV-induced MIP-2 inflammatory protein by 42.8–74.4% at concentrations of 50–500 μg/mL, though these findings have not yet been confirmed in human clinical trials.

Category: Compound Evidence: 1/10 Tier: Preliminary

Origin & History

Ferulic acid is a ubiquitous hydroxycinnamic acid derivative found esterified to cell wall polysaccharides across the plant kingdom, with particularly high concentrations in cereal brans (rice bran ~8 μg/mL, wheat bran ~7.3 μg/mL), bamboo shoots, and seeds of fruits and vegetables. It occurs naturally in Cimicifuga heracleifolia (black cohosh), Ferula species, and numerous grasses of the Poaceae family, from which its name is partly derived. Commercial ferulic acid is predominantly extracted from rice bran or wheat bran via alkaline hydrolysis, enzymatic release, or solvent extraction, with HPLC-based quantification using acetonitrile–acetic acid mobile phases across a linear range of 200–7000 ng/mL.

Historical & Cultural Context

Ferulic acid was first isolated from Ferula foetida (asafoetida), a resin-producing plant used for millennia in Ayurvedic and Persian medicine as a digestive, antispasmodic, and antimicrobial agent, though ferulic acid itself was not distinguished pharmacologically until modern analytical chemistry. In traditional Chinese medicine, Cimicifuga heracleifolia (Sheng Ma) rhizome extracts rich in ferulic acid and related phenolics were employed for antipyretic, anti-inflammatory, and antiviral purposes, predating any knowledge of the compound's molecular identity. Wheat and rice bran, now recognized as primary commercial sources of ferulic acid, have been integral to Asian dietary traditions for centuries, and their health-promoting properties were likely attributable in part to their high phenolic acid content. The compound's formal chemical characterization and naming in the nineteenth century formalized its connection to the genus Ferula, establishing a scientific bridge between ethnobotanical use and modern phytochemical investigation.

Health Benefits

- **Antioxidant Activity**: Ferulic acid donates hydrogen atoms from its phenolic hydroxyl group to neutralize reactive oxygen species; it inhibits lipid peroxidation in methyl linoleate and linoleic acid systems and suppresses intracellular ROS by approximately 76% at 100 μg/mL in RAW 264.7 macrophage cells.
- **Anti-Inflammatory Action**: By suppressing nitric oxide production by ~74% at 100 μg/mL in LPS-stimulated macrophages and reducing pro-inflammatory mediators such as MIP-2, ferulic acid attenuates key inflammatory signaling cascades; these effects are attributed to modulation of redox-sensitive NF-κB pathways.
- **Antiviral Properties**: Ferulic acid and its plant-extract sources inhibit enterovirus 71 (EV71) and coxsackievirus A16 (CVA16) proteases with IC50 values of 40.82 and 47.87 μg/mL, respectively; it also restores intracellular glutathione levels, disrupting redox-dependent viral replication.
- **Neuroprotection (Preclinical)**: Animal studies in rats suggest ferulic acid reaches neural tissues following oral dosing and may reduce oxidative stress-related neuronal damage; its rapid distribution to the heart (14 μg/g), kidney (82 μg/g), and liver (28 μg/g) at 30 minutes post-dose (521 μmol/kg) supports broad tissue bioavailability relevant to neuroprotective strategies.
- **Skin Photoprotection**: At concentrations of approximately 12–14% in topical chemical peel formulations, ferulic acid stabilizes vitamins C and E against UV-induced degradation and independently absorbs UV radiation, reducing oxidative damage to keratinocytes; this synergistic stabilization effect is among its most commercially validated applications.
- **Glutathione Restoration**: Ferulic acid restores depleted cellular glutathione pools in virally infected and oxidatively stressed cell models, reinforcing endogenous antioxidant defense capacity; this mechanism complements its direct radical-scavenging activity and may contribute to hepatoprotective effects observed in animal models.
- **Antimicrobial and Antiviral Breadth**: Beyond enterovirus inhibition, ferulic acid reduced RSV-induced MIP-2 chemokine secretion by 42.8–74.4% across a concentration range of 50–500 μg/mL in murine macrophages, and Cimicifuga heracleifolia leaf extracts rich in ferulic acid demonstrated measurable activity against adenoviruses in cell-based assays.

How It Works

Ferulic acid exerts its primary antioxidant action through hydrogen atom transfer from its para-hydroxyl group, stabilized by resonance across the conjugated propenoic acid side chain, enabling it to quench lipid peroxy radicals and interrupt chain propagation in oxidizable lipid systems such as methyl linoleate. At the cellular level, it suppresses LPS-induced ROS generation and nitric oxide synthesis in macrophages, likely via inhibition of NADPH oxidase activity and downregulation of inducible nitric oxide synthase (iNOS) expression, both of which are regulated by the redox-sensitive transcription factor NF-κB. Its antiviral mechanism involves inhibition of viral cysteine and serine proteases (IC50 40.82–47.87 μg/mL for EV71 and CVA16), restoration of intracellular glutathione to impair redox-dependent viral replication, and suppression of the MIP-2 chemokine response that drives immune-mediated tissue pathology during RSV infection. Esterification of ferulic acid with alkyl chains of varying length modulates its lipophilicity and membrane partitioning, enhancing protection of liposomal membranes against oxidative damage in a chain-length-dependent manner, which has implications for formulation design in both food and pharmaceutical contexts.

Scientific Research

The current evidence base for ferulic acid consists predominantly of in vitro studies using cell lines such as RAW 264.7 murine macrophages and MDCK cells, and animal pharmacokinetic studies in rats, with no human clinical trials reporting specific sample sizes, randomization, or controlled effect sizes identified in available literature. Antioxidant potency data (DPPH assay, ~20% inhibition at 20 μM) places it below caffeic and sinapic acids in direct comparisons, providing an important benchmark for understanding its relative efficacy. Antiviral EC50 values against adenovirus serotypes 8 and 11 (52.5 and 23.3 μg/mL) and viral protease IC50 data (40.82–47.87 μg/mL) were generated in controlled in vitro assays, which represent useful mechanistic proof-of-concept but cannot be directly extrapolated to human therapeutic doses. Human pharmacokinetic data confirm rapid gastrointestinal absorption (peak plasma ~24 min), predominant sulfoglucuronide conjugation (84% of urinary metabolites), and very low fecal recovery (0.5–0.8% in rats), supporting favorable bioavailability, but the translation of preclinical bioactive concentrations to achievable human plasma levels via dietary or supplemental intake remains incompletely characterized.

Clinical Summary

No randomized controlled trials with defined patient populations, primary endpoints, or statistically reported effect sizes are currently available for ferulic acid as an isolated supplement in humans. Human data are limited to pharmacokinetic characterization showing peak plasma concentration at approximately 24 minutes post-ingestion and predominantly renal elimination as sulfoglucuronide conjugates, which establishes absorptive feasibility but not therapeutic efficacy. Topical ferulic acid in combination formulations (e.g., with ascorbic acid and tocopherol at ~0.5%) has been studied in dermatological contexts for photoprotection, representing one of the more clinically advanced applications, though head-to-head RCT data with robust sample sizes remain sparse. The overall clinical confidence in ferulic acid for systemic applications such as neuroprotection, antiviral therapy, or anti-inflammation is low at present, and future well-powered human trials are needed to validate the compelling preclinical signal.

Nutritional Profile

Ferulic acid is a non-caloric, low-molecular-weight phenolic acid (MW 194.18 g/mol) rather than a macronutrient, and it contributes negligibly to caloric intake at dietary concentrations. In whole food sources, it occurs primarily esterified to arabinoxylans and other cell wall polysaccharides, requiring esterase or alkaline hydrolysis for liberation; this bound form significantly limits bioavailability compared to free ferulic acid, with intestinal microbial esterases playing a key role in colonic release. Rice bran provides approximately 8 μg/mL and wheat bran approximately 7.3 μg/mL of measurable ferulic acid by HPLC; related diferulic acid dimers (8,5′-, 5,5′-, 8,4′-, 8,8′-diFA) and higher oligomers co-occur and may contribute additive antioxidant activity. Bioavailability in humans is characterized by rapid absorption (peak ~24 min), extensive phase II conjugation yielding predominantly sulfoglucuronides (84% of urinary metabolites), and minimal fecal loss (0.5–0.8% in rats), indicating efficient systemic uptake when ferulic acid is in its free form.

Preparation & Dosage

- **Pure Ferulic Acid Powder (Oral Supplement)**: No evidence-based standard dose established; preclinical non-cytotoxic concentrations of 25–100 μg/mL in cell assays do not directly translate to oral mg doses without validated pharmacokinetic modeling.
- **Plant Extract Sources**: Rice bran and wheat bran extracts provide approximately 7.3–8 μg/mL ferulic acid; whole grain consumption represents the most common dietary exposure route without standardized supplemental dosing.
- **Topical Formulations**: Chemical peel preparations use ferulic acid at approximately 12–14%; cosmetic serums typically combine 0.5% ferulic acid with 15% L-ascorbic acid and 1% α-tocopherol for photoprotective synergy.
- **Ester Forms (Alkyl Ferulates)**: Synthesized for enhanced lipophilicity and membrane protection; chain length optimization is formulation-specific and used primarily in functional food and cosmetic applications rather than oral supplementation.
- **Timing Note**: Based on human pharmacokinetic data, peak plasma levels are achieved rapidly (~24 min), suggesting ferulic acid from food or supplements is absorbed in the proximal gastrointestinal tract; co-ingestion with lipid-containing meals may influence esterase-mediated release from plant matrix.

Synergy & Pairings

Ferulic acid is most established as a synergist in topical antioxidant formulations, where it stabilizes both L-ascorbic acid (vitamin C) and α-tocopherol (vitamin E) against photodegradation, doubling the photoprotective efficacy of combined vitamin C and E serums; this stabilization is mediated by ferulic acid's UV absorption properties and its ability to regenerate oxidized vitamin E via electron transfer. In the context of antioxidant stacking for systemic use, ferulic acid may complement quercetin and resveratrol through complementary radical-scavenging mechanisms (hydrogen atom transfer vs. electron transfer) and overlapping NF-κB inhibition, though this combination has not been validated in human clinical trials. Its glutathione-restoring activity suggests potential synergy with N-acetylcysteine (NAC) as a precursor to glutathione biosynthesis, providing both direct scavenging and endogenous antioxidant replenishment in oxidatively stressed conditions.

Safety & Interactions

Ferulic acid demonstrated no cytotoxicity at concentrations up to 100 μg/mL in RAW 264.7 macrophage cell cultures, and no adverse effects have been reported in animal pharmacokinetic studies at doses up to 521 μmol/kg; however, long-term safety data in humans at supplemental doses are not available from published clinical trials. No specific drug interactions have been characterized in controlled human studies; given its inhibition of nitric oxide synthase and potential modulation of NF-κB signaling, theoretical interactions with immunosuppressants, antihypertensives, or anticoagulants cannot be excluded and warrant caution in vulnerable populations. No contraindications, maximum tolerated doses, or pregnancy and lactation safety data are currently established from human evidence, and its use during pregnancy or breastfeeding should be approached conservatively until adequate safety studies are conducted. Topical application at 12–14% concentrations in chemical peels carries standard dermatological risks of irritation and photosensitization in sensitive skin types, and patch testing is advisable prior to clinical use.